Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,384 | 576 | 96.7% |
| Education | $255.48 | 3 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,117 | 87 | $0 (2024) |
| Lilly USA, LLC | $992.55 | 80 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $976.20 | 91 | $0 (2024) |
| LEO Pharma Inc. | $662.31 | 45 | $0 (2024) |
| Janssen Biotech, Inc. | $435.44 | 19 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $281.43 | 21 | $0 (2024) |
| UCB, Inc. | $276.11 | 19 | $0 (2024) |
| GENZYME CORPORATION | $256.78 | 17 | $0 (2024) |
| PFIZER INC. | $252.32 | 17 | $0 (2024) |
| Dermavant Sciences, Inc. | $233.03 | 32 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,552 | 131 | Novartis Pharmaceuticals Corporation ($326.73) |
| 2023 | $1,113 | 75 | Novartis Pharmaceuticals Corporation ($250.53) |
| 2022 | $726.24 | 55 | ABBVIE INC. ($135.78) |
| 2021 | $872.29 | 68 | AbbVie Inc. ($193.00) |
| 2020 | $521.31 | 40 | Lilly USA, LLC ($135.18) |
| 2019 | $884.72 | 69 | Novartis Pharmaceuticals Corporation ($154.00) |
| 2018 | $942.78 | 77 | LEO Pharma Inc. ($167.34) |
| 2017 | $1,027 | 64 | Lilly USA, LLC ($156.42) |
All Payment Transactions
579 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.53 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $9.48 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.68 | General |
| Category: Immunology | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $0.61 | General |
| Category: Immunology | ||||||
| 12/02/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Immunology | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.02 | General |
| Category: Immunology | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $4.64 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $2.62 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $9.16 | General |
| Category: Immunology | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $12.97 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $9.12 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Immunology | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Immunology | ||||||
| 10/28/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: DERMATOLOGY | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $9.32 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,112 | 3,360 | $369,622 | $179,180 |
| 2022 | 19 | 1,719 | 2,602 | $282,386 | $148,165 |
| 2021 | 19 | 1,617 | 2,277 | $271,287 | $147,721 |
| 2020 | 18 | 1,538 | 2,098 | $246,209 | $122,884 |
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 672 | 895 | $107,400 | $58,517 | 54.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 235 | 294 | $42,620 | $22,239 | 52.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 354 | 468 | $51,480 | $20,762 | 40.3% |
| 14021 | Repair of wound of scalp, arms, or legs by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 13 | 13 | $17,186 | $9,954 | 57.9% |
| 14040 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | Office | 2023 | 11 | 13 | $17,186 | $8,719 | 50.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 88 | 95 | $15,200 | $8,220 | 54.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 43 | 54 | $16,200 | $7,877 | 48.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 133 | 157 | $11,760 | $6,663 | 56.7% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 36 | 40 | $14,000 | $6,025 | 43.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 240 | 1,003 | $30,090 | $5,758 | 19.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 66 | 66 | $9,900 | $5,233 | 52.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 74 | 108 | $7,560 | $4,865 | 64.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 37 | $6,290 | $3,238 | 51.5% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 19 | 19 | $6,650 | $2,457 | 36.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 11 | 13 | $3,120 | $1,966 | 63.0% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 13 | $2,470 | $1,543 | 62.5% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 13 | 15 | $2,550 | $1,434 | 56.2% |
| 10040 | Acne surgery | Office | 2023 | 14 | 14 | $2,240 | $1,407 | 62.8% |
| 69100 | Biopsy of ear | Office | 2023 | 18 | 18 | $2,520 | $957.28 | 38.0% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 11 | 11 | $1,870 | $902.83 | 48.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 14 | 14 | $1,330 | $443.24 | 33.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 573 | 795 | $87,450 | $52,762 | 60.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 217 | 280 | $37,800 | $21,434 | 56.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 255 | 343 | $37,730 | $15,176 | 40.2% |
| 14040 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | Office | 2022 | 13 | 13 | $17,186 | $8,693 | 50.6% |
About Dr. David High, MD
Dr. David High, MD is a Dermatology healthcare provider based in Medford, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972554400.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David High, MD has received a total of $7,640 in payments from pharmaceutical and medical device companies, with $1,552 received in 2024. These payments were reported across 579 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($7,384).
As a Medicare-enrolled provider, High has provided services to 6,986 Medicare beneficiaries, totaling 10,337 services with total Medicare billing of $597,950. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Medford, NJ
- Active Since 05/12/2006
- Last Updated 07/20/2015
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1972554400
Products in Payments
- TALTZ (Drug) $992.55
- SKYRIZI (Biological) $627.40
- COSENTYX (Drug) $545.96
- ENSTILAR (Drug) $399.51
- COSENTYX (Biological) $398.94
- DUPIXENT (Biological) $322.44
- Sotyktu (Drug) $270.41
- Humira (Biological) $252.57
- EUCRISA (Drug) $252.32
- VTAMA (Drug) $233.03
- TREMFYA (Drug) $232.14
- Cimzia (Drug) $197.22
- ADBRY (Biological) $191.97
- Otezla (Drug) $191.03
- RINVOQ (Biological) $178.57
- Erivedge (Biological) $174.23
- DORYX (Drug) $156.71
- REMICADE (Biological) $151.00
- Bimzelx (Biological) $78.89
- NAFTIN (Drug) $76.39
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Medford
Mrs. Elyse Harrop, Md, MD
Dermatology — Payments: $8,322
Dr. Andrea Buck, Do, DO
Dermatology — Payments: $6,748
Dr. David Trask, M.d, M.D
Dermatology — Payments: $2,988
Timothy Maccurdy, P.a, P.A
Dermatology — Payments: $1,835
Jennifer Barklund, Md, MD
Dermatology — Payments: $1,612
Nikki Tang, M.d, M.D
Dermatology — Payments: $657.13